1. Structure and toxicity of Amphotericin B/triglyceride emulsion formulations;Lance;J. Antimicrob. Chemother.,1995
2. S.S. Davis, C. Washington, Drug emulsion, European Patent 0 296 845 A1 (1988).
3. An emulsion formulation of Amphotericin B improves the therapeutic index when treating systemic murine candidiasis;Kirsh;J. Infect. Dis.,1988
4. Efficacy and tolerance of an Amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients;Caillot;J. Antimicrob. Chemother.,1993
5. I. Buttle, S. Schmidt, R.H. Müller, Production of Amphotericin B emulsions based on SolEmuls technology, 4th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Florence, April 8–11, 2002, 1535–1536.